AustralieFrV1, PascalFrancis, Corpus, bibRecord, 002319

Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study

Identifieur interne : 002319 ( PascalFrancis/Corpus ); précédent : 002318; suivant : 002320

Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study

Auteurs : C. C. Lee ; R. P. Stolk ; A. I. Adler ; A. Patel ; J. Chalmers ; B. Neal ; N. Poulter ; S. Harrap ; M. Woodward ; M. Marre ; D. E. Grobbee ; J. W. Beulens

Source :

Diabetic medicine [ 0742-3071 ] ; 2010.

RBID : Pascal:10-0462497

Descripteurs français

Pascal (Inist)
- Diabète, Association, Boisson alcoolisée, Rétinopathie, Consommation, Acuité visuelle, Endocrinologie, Maladie métabolique, Nutrition, Obésité, Etat nutritionnel.

English descriptors

KwdEn :
- Alcoholic beverage, Association, Consumption, Diabetes mellitus, Endocrinology, Metabolic diseases, Nutrition, Nutritional status, Obesity, Retinopathy, Visual acuity.

Abstract

Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0742-3071`
A02	`01`			`@0 DIMEEV`
A03		`1`		`@0 Diabetic med.`
A05				`@2 27`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study`
A11	`01`	`1`		`@1 LEE (C. C.)`
A11	`02`	`1`		`@1 STOLK (R. P.)`
A11	`03`	`1`		`@1 ADLER (A. I.)`
A11	`04`	`1`		`@1 PATEL (A.)`
A11	`05`	`1`		`@1 CHALMERS (J.)`
A11	`06`	`1`		`@1 NEAL (B.)`
A11	`07`	`1`		`@1 POULTER (N.)`
A11	`08`	`1`		`@1 HARRAP (S.)`
A11	`09`	`1`		`@1 WOODWARD (M.)`
A11	`10`	`1`		`@1 MARRE (M.)`
A11	`11`	`1`		`@1 GROBBEE (D. E.)`
A11	`12`	`1`		`@1 BEULENS (J. W.)`
A14	`01`			`@1 MRC Epidemiology Unit, Institute of Metabolic Science @2 Cambridge @3 GBR @Z 1 aut. @Z 3 aut.`
A14	`02`			`@1 University Medical Centre Groningen @3 GBR @Z 2 aut.`
A14	`03`			`@1 University Medical Centre Utrecht @3 NLD @Z 2 aut. @Z 11 aut. @Z 12 aut.`
A14	`04`			`@1 Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science @2 Cambridge @3 GBR @Z 3 aut.`
A14	`05`			`@1 George Institute of International Health @2 Sydney, NSW @3 AUS @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 9 aut.`
A14	`06`			`@1 Imperial College and St Mary's Hospital @2 London @3 GBR @Z 7 aut.`
A14	`07`			`@1 University of Melbourne @2 Melbourne @3 AUS @Z 8 aut.`
A14	`08`			`@1 Mount Sinai School of Medicine @2 New York, NY @3 USA @Z 9 aut.`
A14	`09`			`@1 Hôpital Bichat-Claude Bernard and Université Paris @2 Paris @3 FRA @Z 10 aut.`
A17	`01`	`1`		`@1 AdRem project team and ADVANCE management committee @3 INC`
A20				`@1 1130-1137`
A21				`@1 2010`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20274 @5 354000191300700050`
A44				`@0 0000 @1 © 2010 INIST-CNRS. All rights reserved.`
A45				`@0 33 ref.`
A47	`01`	`1`		`@0 10-0462497`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Diabetic medicine`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.
C02	`01`	`X`		`@0 002A16E`
C02	`02`	`X`		`@0 002A28`
C02	`03`	`X`		`@0 002B21E01A`
C03	`01`	`X`	`FRE`	`@0 Diabète @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Diabetes mellitus @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Diabetes @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Association @5 02`
C03	`02`	`X`	`ENG`	`@0 Association @5 02`
C03	`02`	`X`	`SPA`	`@0 Asociación @5 02`
C03	`03`	`X`	`FRE`	`@0 Boisson alcoolisée @2 FX @5 03`
C03	`03`	`X`	`ENG`	`@0 Alcoholic beverage @2 FX @5 03`
C03	`03`	`X`	`SPA`	`@0 Bebida alcohólica @2 FX @5 03`
C03	`04`	`X`	`FRE`	`@0 Rétinopathie @5 04`
C03	`04`	`X`	`ENG`	`@0 Retinopathy @5 04`
C03	`04`	`X`	`SPA`	`@0 Retinopatía @5 04`
C03	`05`	`X`	`FRE`	`@0 Consommation @5 05`
C03	`05`	`X`	`ENG`	`@0 Consumption @5 05`
C03	`05`	`X`	`SPA`	`@0 Consumo @5 05`
C03	`06`	`X`	`FRE`	`@0 Acuité visuelle @5 06`
C03	`06`	`X`	`ENG`	`@0 Visual acuity @5 06`
C03	`06`	`X`	`SPA`	`@0 Acuidad visual @5 06`
C03	`07`	`X`	`FRE`	`@0 Endocrinologie @5 08`
C03	`07`	`X`	`ENG`	`@0 Endocrinology @5 08`
C03	`07`	`X`	`SPA`	`@0 Endocrinología @5 08`
C03	`08`	`X`	`FRE`	`@0 Maladie métabolique @5 09`
C03	`08`	`X`	`ENG`	`@0 Metabolic diseases @5 09`
C03	`08`	`X`	`SPA`	`@0 Metabolismo patología @5 09`
C03	`09`	`X`	`FRE`	`@0 Nutrition @5 11`
C03	`09`	`X`	`ENG`	`@0 Nutrition @5 11`
C03	`09`	`X`	`SPA`	`@0 Nutrición @5 11`
C03	`10`	`X`	`FRE`	`@0 Obésité @5 12`
C03	`10`	`X`	`ENG`	`@0 Obesity @5 12`
C03	`10`	`X`	`SPA`	`@0 Obesidad @5 12`
C03	`11`	`X`	`FRE`	`@0 Etat nutritionnel @5 25`
C03	`11`	`X`	`ENG`	`@0 Nutritional status @5 25`
C03	`11`	`X`	`SPA`	`@0 Estado nutricional @5 25`
C07	`01`	`X`	`FRE`	`@0 Endocrinopathie @5 37`
C07	`01`	`X`	`ENG`	`@0 Endocrinopathy @5 37`
C07	`01`	`X`	`SPA`	`@0 Endocrinopatía @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie de l'oeil @5 38`
C07	`02`	`X`	`ENG`	`@0 Eye disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Ojo patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Trouble de la nutrition @5 39`
C07	`03`	`X`	`ENG`	`@0 Nutrition disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Trastorno nutricíon @5 39`
N21				`@1 298`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 10-0462497 INIST
ET :	Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study
AU :	LEE (C. C.); STOLK (R. P.); ADLER (A. I.); PATEL (A.); CHALMERS (J.); NEAL (B.); POULTER (N.); HARRAP (S.); WOODWARD (M.); MARRE (M.); GROBBEE (D. E.); BEULENS (J. W.)
AF :	MRC Epidemiology Unit, Institute of Metabolic Science/Cambridge/Royaume-Uni (1 aut., 3 aut.); University Medical Centre Groningen/Royaume-Uni (2 aut.); University Medical Centre Utrecht/Pays-Bas (2 aut., 11 aut., 12 aut.); Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science/Cambridge/Royaume-Uni (3 aut.); George Institute of International Health/Sydney, NSW/Australie (4 aut., 5 aut., 6 aut., 9 aut.); Imperial College and St Mary's Hospital/London/Royaume-Uni (7 aut.); University of Melbourne/Melbourne/Australie (8 aut.); Mount Sinai School of Medicine/New York, NY/Etats-Unis (9 aut.); Hôpital Bichat-Claude Bernard and Université Paris/Paris/France (10 aut.)
DT :	Publication en série; Niveau analytique
SO :	Diabetic medicine; ISSN 0742-3071; Coden DIMEEV; Royaume-Uni; Da. 2010; Vol. 27; No. 10; Pp. 1130-1137; Bibl. 33 ref.
LA :	Anglais
EA :	Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.
CC :	002A16E; 002A28; 002B21E01A
FD :	Diabète; Association; Boisson alcoolisée; Rétinopathie; Consommation; Acuité visuelle; Endocrinologie; Maladie métabolique; Nutrition; Obésité; Etat nutritionnel
FG :	Endocrinopathie; Pathologie de l'oeil; Trouble de la nutrition
ED :	Diabetes mellitus; Association; Alcoholic beverage; Retinopathy; Consumption; Visual acuity; Endocrinology; Metabolic diseases; Nutrition; Obesity; Nutritional status
EG :	Endocrinopathy; Eye disease; Nutrition disorder
SD :	Diabetes; Asociación; Bebida alcohólica; Retinopatía; Consumo; Acuidad visual; Endocrinología; Metabolismo patología; Nutrición; Obesidad; Estado nutricional
LO :	INIST-20274.354000191300700050
ID :	10-0462497

Links to Exploration step

Pascal:10-0462497

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study</title>
<author><name sortKey="Lee, C C" sort="Lee, C C" uniqKey="Lee C" first="C. C." last="Lee">C. C. Lee</name>
<affiliation><inist:fA14 i1="01"><s1>MRC Epidemiology Unit, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stolk, R P" sort="Stolk, R P" uniqKey="Stolk R" first="R. P." last="Stolk">R. P. Stolk</name>
<affiliation><inist:fA14 i1="02"><s1>University Medical Centre Groningen</s1>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adler, A I" sort="Adler, A I" uniqKey="Adler A" first="A. I." last="Adler">A. I. Adler</name>
<affiliation><inist:fA14 i1="01"><s1>MRC Epidemiology Unit, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Patel, A" sort="Patel, A" uniqKey="Patel A" first="A." last="Patel">A. Patel</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J." last="Chalmers">J. Chalmers</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Neal, B" sort="Neal, B" uniqKey="Neal B" first="B." last="Neal">B. Neal</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poulter, N" sort="Poulter, N" uniqKey="Poulter N" first="N." last="Poulter">N. Poulter</name>
<affiliation><inist:fA14 i1="06"><s1>Imperial College and St Mary's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harrap, S" sort="Harrap, S" uniqKey="Harrap S" first="S." last="Harrap">S. Harrap</name>
<affiliation><inist:fA14 i1="07"><s1>University of Melbourne</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Woodward, M" sort="Woodward, M" uniqKey="Woodward M" first="M." last="Woodward">M. Woodward</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Mount Sinai School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marre, M" sort="Marre, M" uniqKey="Marre M" first="M." last="Marre">M. Marre</name>
<affiliation><inist:fA14 i1="09"><s1>Hôpital Bichat-Claude Bernard and Université Paris</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grobbee, D E" sort="Grobbee, D E" uniqKey="Grobbee D" first="D. E." last="Grobbee">D. E. Grobbee</name>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Beulens, J W" sort="Beulens, J W" uniqKey="Beulens J" first="J. W." last="Beulens">J. W. Beulens</name>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0462497</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0462497 INIST</idno>
<idno type="RBID">Pascal:10-0462497</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002319</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study</title>
<author><name sortKey="Lee, C C" sort="Lee, C C" uniqKey="Lee C" first="C. C." last="Lee">C. C. Lee</name>
<affiliation><inist:fA14 i1="01"><s1>MRC Epidemiology Unit, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stolk, R P" sort="Stolk, R P" uniqKey="Stolk R" first="R. P." last="Stolk">R. P. Stolk</name>
<affiliation><inist:fA14 i1="02"><s1>University Medical Centre Groningen</s1>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Adler, A I" sort="Adler, A I" uniqKey="Adler A" first="A. I." last="Adler">A. I. Adler</name>
<affiliation><inist:fA14 i1="01"><s1>MRC Epidemiology Unit, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Patel, A" sort="Patel, A" uniqKey="Patel A" first="A." last="Patel">A. Patel</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J." last="Chalmers">J. Chalmers</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Neal, B" sort="Neal, B" uniqKey="Neal B" first="B." last="Neal">B. Neal</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poulter, N" sort="Poulter, N" uniqKey="Poulter N" first="N." last="Poulter">N. Poulter</name>
<affiliation><inist:fA14 i1="06"><s1>Imperial College and St Mary's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harrap, S" sort="Harrap, S" uniqKey="Harrap S" first="S." last="Harrap">S. Harrap</name>
<affiliation><inist:fA14 i1="07"><s1>University of Melbourne</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Woodward, M" sort="Woodward, M" uniqKey="Woodward M" first="M." last="Woodward">M. Woodward</name>
<affiliation><inist:fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Mount Sinai School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marre, M" sort="Marre, M" uniqKey="Marre M" first="M." last="Marre">M. Marre</name>
<affiliation><inist:fA14 i1="09"><s1>Hôpital Bichat-Claude Bernard and Université Paris</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grobbee, D E" sort="Grobbee, D E" uniqKey="Grobbee D" first="D. E." last="Grobbee">D. E. Grobbee</name>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Beulens, J W" sort="Beulens, J W" uniqKey="Beulens J" first="J. W." last="Beulens">J. W. Beulens</name>
<affiliation><inist:fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Diabetic medicine</title>
<title level="j" type="abbreviated">Diabetic med.</title>
<idno type="ISSN">0742-3071</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Diabetic medicine</title>
<title level="j" type="abbreviated">Diabetic med.</title>
<idno type="ISSN">0742-3071</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alcoholic beverage</term>
<term>Association</term>
<term>Consumption</term>
<term>Diabetes mellitus</term>
<term>Endocrinology</term>
<term>Metabolic diseases</term>
<term>Nutrition</term>
<term>Nutritional status</term>
<term>Obesity</term>
<term>Retinopathy</term>
<term>Visual acuity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Diabète</term>
<term>Association</term>
<term>Boisson alcoolisée</term>
<term>Rétinopathie</term>
<term>Consommation</term>
<term>Acuité visuelle</term>
<term>Endocrinologie</term>
<term>Maladie métabolique</term>
<term>Nutrition</term>
<term>Obésité</term>
<term>Etat nutritionnel</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0742-3071</s0>
</fA01>
<fA02 i1="01"><s0>DIMEEV</s0>
</fA02>
<fA03 i2="1"><s0>Diabetic med.</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LEE (C. C.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STOLK (R. P.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>ADLER (A. I.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PATEL (A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>CHALMERS (J.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>NEAL (B.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>POULTER (N.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HARRAP (S.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>WOODWARD (M.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MARRE (M.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>GROBBEE (D. E.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>BEULENS (J. W.)</s1>
</fA11>
<fA14 i1="01"><s1>MRC Epidemiology Unit, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University Medical Centre Groningen</s1>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>University Medical Centre Utrecht</s1>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>George Institute of International Health</s1>
<s2>Sydney, NSW</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Imperial College and St Mary's Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>University of Melbourne</s1>
<s2>Melbourne</s2>
<s3>AUS</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Mount Sinai School of Medicine</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Hôpital Bichat-Claude Bernard and Université Paris</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1"><s1>AdRem project team and ADVANCE management committee</s1>
<s3>INC</s3>
</fA17>
<fA20><s1>1130-1137</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20274</s2>
<s5>354000191300700050</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>33 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0462497</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Diabetic medicine</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A16E</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002A28</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B21E01A</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Diabète</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Diabetes mellitus</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Diabetes</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Association</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Association</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Asociación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Boisson alcoolisée</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Alcoholic beverage</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Bebida alcohólica</s0>
<s2>FX</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Rétinopathie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Retinopathy</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Retinopatía</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Consommation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Consumption</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Consumo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Acuité visuelle</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Visual acuity</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Acuidad visual</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Endocrinologie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Endocrinology</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Endocrinología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Maladie métabolique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Nutrition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Nutrition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Nutrición</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Obésité</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Obesity</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Obesidad</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Etat nutritionnel</s0>
<s5>25</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Nutritional status</s0>
<s5>25</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Estado nutricional</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Endocrinopathie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Endocrinopathy</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Endocrinopatía</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'oeil</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Trouble de la nutrition</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nutrition disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Trastorno nutricíon</s0>
<s5>39</s5>
</fC07>
<fN21><s1>298</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0462497 INIST</NO>
<ET>Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study</ET>
<AU>LEE (C. C.); STOLK (R. P.); ADLER (A. I.); PATEL (A.); CHALMERS (J.); NEAL (B.); POULTER (N.); HARRAP (S.); WOODWARD (M.); MARRE (M.); GROBBEE (D. E.); BEULENS (J. W.)</AU>
<AF>MRC Epidemiology Unit, Institute of Metabolic Science/Cambridge/Royaume-Uni (1 aut., 3 aut.); University Medical Centre Groningen/Royaume-Uni (2 aut.); University Medical Centre Utrecht/Pays-Bas (2 aut., 11 aut., 12 aut.); Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science/Cambridge/Royaume-Uni (3 aut.); George Institute of International Health/Sydney, NSW/Australie (4 aut., 5 aut., 6 aut., 9 aut.); Imperial College and St Mary's Hospital/London/Royaume-Uni (7 aut.); University of Melbourne/Melbourne/Australie (8 aut.); Mount Sinai School of Medicine/New York, NY/Etats-Unis (9 aut.); Hôpital Bichat-Claude Bernard and Université Paris/Paris/France (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Diabetic medicine; ISSN 0742-3071; Coden DIMEEV; Royaume-Uni; Da. 2010; Vol. 27; No. 10; Pp. 1130-1137; Bibl. 33 ref.</SO>
<LA>Anglais</LA>
<EA>Aims We investigated the association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes. Methods We conducted a cohort analysis of 1239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial. Current and past consumption of wine, spirits and beer was measured by self-report. Moderate and heavy alcohol consumption was defined as 1-14 and > 14 drinks/week, respectively. Diabetic retinopathy, measured by mydriatic stereoscopic seven-field retinal photography, was defined by a 2-step progression in the Early Treatment of Diabetic Retinopathy Study (ETDRS) score or the presence of any retinal vascular lesions. Deterioration of visual acuity was defined by a decrease of two lines in best vision in either eye, measured corrected, or through a pinhole using a Snellen chart. Results In a mean follow-up of 5.5 years, we identified 182 participants with a 2-step progression in the ETDRS score, 640 participants with the presence of any retinal vascular lesions and 693 participants with a deterioration of visual acuity. Current moderate consumption of alcohol, compared with no current consumption, was not associated with presence or progression of diabetic retinopathy; however, it was associated with higher risk of deterioration of visual acuity (multivariable-adjusted OR 1.83; 95% CI 1.34-2.48; P < 0.001). Conclusions Alcohol consumption is associated with increased risk of deterioration of visual acuity, but not with retinopathy in individuals with Type 2 diabetes.</EA>
<CC>002A16E; 002A28; 002B21E01A</CC>
<FD>Diabète; Association; Boisson alcoolisée; Rétinopathie; Consommation; Acuité visuelle; Endocrinologie; Maladie métabolique; Nutrition; Obésité; Etat nutritionnel</FD>
<FG>Endocrinopathie; Pathologie de l'oeil; Trouble de la nutrition</FG>
<ED>Diabetes mellitus; Association; Alcoholic beverage; Retinopathy; Consumption; Visual acuity; Endocrinology; Metabolic diseases; Nutrition; Obesity; Nutritional status</ED>
<EG>Endocrinopathy; Eye disease; Nutrition disorder</EG>
<SD>Diabetes; Asociación; Bebida alcohólica; Retinopatía; Consumo; Acuidad visual; Endocrinología; Metabolismo patología; Nutrición; Obesidad; Estado nutricional</SD>
<LO>INIST-20274.354000191300700050</LO>
<ID>10-0462497</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002319 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002319 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0462497
   |texte=   Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study

Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri